InvestorsHub Logo
Followers 367
Posts 10725
Boards Moderated 0
Alias Born 04/19/2008

Re: RadInvest post# 81549

Wednesday, 03/06/2019 10:53:20 PM

Wednesday, March 06, 2019 10:53:20 PM

Post# of 100623
Multiple Sources of Revenue Projected to Produce$3 Million in Sales in 2019

Additional revenue or potential revenue indicator extracts from BLDV 3/6/19 PR:

1. Bundled IP together with specialized equipment will allow H360 to increase the value of existing projects.

2. “We have doubled the size of the Virginia contract by bringing together all of the components required to produce Cannareet™ under one agreement

3. “H360 was already a major supplier to the project and the all inclusive package will ensure that the tech management will fall under one contract

4. A similar package is being offered to Cavalry Cannabis, in Kansas City, this time using The Athena Protocol as the licensed product offering and research platform.

5. Gofire MoU: H360 will be active in New York, New jersey, Virginia,Missouri and Florida to start, and will work to integrate the gofire solutions into major markets in the Eastern USA.

6. Gofire MoU: Revenue will be based on expansion of DoseCode program, acquisition of oil cartridge partners in the territories, and data collection that will lead to improved doctor directed therapies.

7. Virginia is projected to be a single P.O. for just under 1 Million USD, and other projects in progress total over 2 Million USD.

8. A single Cannareet™ license may include Genetics, Cultivation Recipes, Extraction details, Formulation instructions, Packaging requirements, Labeling requirements, Doctor training, Patient Marketing, Data feedback , and more. Each component we can add, increases the revenue potential for BLDV and H360 fulfills that role.

9. Now that the company is current in it’s reporting, revenue acquisition is the focus for the second quarter of 2019 and beyond.


Extracts source - BLDV 3/6/19 PR: https://backend.otcmarkets.com/otcapi/company/dns/news/document/35281/content

- Based on the 3/6/19 PR, it seems like BLDV is finally focused on the right and more important key success factor which is generating revenues. This is long overdue and it is good to see at last.

Go BLDV!

Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.